Gene of the month: HGF

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Clinical Pathology

• Publication date

  2016-04-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1136/jclinpath-2015-203575PMID 27072686
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma

  2015cited by this paper
• Met endosomal signalling: in the right place, at the right time.

  2014cited by this paper
• Unmet needs and challenges in gastric cancer: the way forward.

  2014cited by this paper
• HGF–Met Pathway in Regeneration and Drug Discovery

  2014cited by this paper
• The Met receptor tyrosine kinase: a key player in oncogenesis and drug resistance.

  2014cited by this paper
• The Hepatocyte Growth Factor (HGF)/Met Axis: A Neglected Target in the Treatment of Chronic Myeloproliferative Neoplasms?

  2014cited by this paper
• Serum levels of hepatocyte growth factor and epiregulin are associated with the prognosis on anti-EGFR antibody treatment in KRAS wild-type metastatic colorectal cancer

  2014cited by this paper
• Advances in liver regeneration

  2014cited by this paper
• HGF/MET-directed therapeutics in gastroesophageal cancer: a review of clinical and biomarker development

  2014cited by this paper
• HER2, MET and FGFR2 oncogenic driver alterations define distinct molecular segments for targeted therapies in gastric carcinoma

  2014cited by this paper
• Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study.

  2013cited by this paper
• The genomic landscape of oesophagogastric junctional adenocarcinoma

  2013cited by this paper
• A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis

  2013cited by this paper
• GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012

  2013cited by this paper
• Targeting the HGF-cMET Axis in Hepatocellular Carcinoma

  2013cited by this paper
• HGF-MET signals via the MLL-ETS2 complex in hepatocellular carcinoma.

  2013cited by this paper
• Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies.

  2012cited by this paper
• Liver regeneration.

  2012cited by this paper
• Targeting the HGF/Met signaling pathway in cancer therapy

  2012cited by this paper
• MET amplification as a potential therapeutic target in gastric cancer

  2012cited by this paper
• Microenvironmental regulation of epithelial-mesenchymal transitions in cancer.

  2012cited by this paper
• MET Expression and Amplification in Patients with Localized Gastric Cancer

  2011cited by this paper
• Hepatocyte growth factor twenty years on: Much more than a growth factor

  2011cited by this paper
• MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib.

  2011cited by this paper
• Targeted treatments in colorectal cancer: state of the art and future perspectives

  2010cited by this paper
• The role of signaling pathways in the development and treatment of hepatocellular carcinoma

  2010cited by this paper
• MET signalling: principles and functions in development, organ regeneration and cancer

  2010cited by this paper
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010cited by this paper
• HEPATOCYTE GROWTH FACTOR : ITS ROLE IN HEPATIC GROWTH AND PATHOBIOLOGY

  2009cited by this paper
• Novel Therapeutic Inhibitors of the c-Met Signaling Pathway in Cancer

  2009cited by this paper
• Noncoding mutations of HGF are associated with nonsyndromic hearing loss, DFNB39.

  2009cited by this paper
• Role of overexpression of CD151 and/or c‐Met in predicting prognosis of hepatocellular carcinoma

  2009cited by this paper
• HGF Rescues Colorectal Cancer Cells from EGFR Inhibition via MET Activation

  2009cited by this paper
• Drug development of MET inhibitors: targeting oncogene addiction and expedience

  2008cited by this paper
• c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases.

  2008cited by this paper
• Single-Agent and Combination Therapeutic Strategies to Inhibit Hepatocyte Growth Factor/MET Signaling in Cancer

  2008cited by this paper
• Prognostic Factors and Recurrence of Small Hepatocellular Carcinoma after Hepatic Resection or Microwave Ablation: A Retrospective Study

  2008cited by this paper
• Clinical significance of serum HGF and c-Met expression in tumor tissue for evaluation of properties and treatment of hepatocellular carcinoma.

  2008cited by this paper
• Cetuximab for the treatment of colorectal cancer.

  2007cited by this paper
• Liver regeneration

  2007cited by this paper
• c-Met and hepatocyte growth factor: Potential as novel targets in cancer therapy

  2007cited by this paper
• Migration of Bone Marrow and Cord Blood Mesenchymal Stem Cells In Vitro Is Regulated by Stromal‐Derived Factor‐1‐CXCR4 and Hepatocyte Growth Factor‐c‐met Axes and Involves Matrix Metalloproteinases

  2006cited by this paper
• Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype.

  2006cited by this paper
• [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].

  2006cited by this paper
• Defect of pro-hepatocyte growth factor activation by fibroblasts in idiopathic pulmonary fibrosis.

  2006cited by this paper
• Thinking outside the cell: proteases regulate hepatocyte division.

  2005cited by this paper
• Regeneration of injured intestinal mucosa is impaired in hepatocyte growth factor activator-deficient mice.

  2004cited by this paper
• Association between serum hepatocyte growth factor and survival in untreated hepatocellular carcinoma

  2004cited by this paper
• Cetuximab in the treatment of colorectal cancer.

  2004cited by this paper
• Proapoptotic Function of the MET Tyrosine Kinase Receptor through Caspase Cleavage

  2004cited by this paper
• Escape from Cbl-mediated downregulation: a recurrent theme for oncogenic deregulation of receptor tyrosine kinases.

  2003cited by this paper
• Hepatocyte growth factor, transforming growth factor alpha, and their receptors as combined markers of prognosis in hepatocellular carcinoma.

  2003cited by this paper
• Hepatocyte growth factor, transforming growth factor α, and their receptors as combined markers of prognosis in hepatocellular carcinoma

  2003cited by this paper
• Activation of NF-κB Is Essential for Hepatocyte Growth Factor-Mediated Proliferation and Tubulogenesis

  2002cited by this paper
• The Tyrosine Phosphatase SHP-2 Is Required for Sustained Activation of Extracellular Signal-Regulated Kinase and Epithelial Morphogenesis Downstream from the Met Receptor Tyrosine Kinase

  2000cited by this paper
• A novel germ line juxtamembrane Met mutation in human gastric cancer

  2000cited by this paper
• The Gab1 PH Domain Is Required for Localization of Gab1 at Sites of Cell-Cell Contact and Epithelial Morphogenesis Downstream from the Met Receptor Tyrosine Kinase

  1999cited by this paper
• Increased level of serum hepatocyte growth factor/scatter factor in liver cancer is associated with tumor metastasis.

  1999cited by this paper
• Expression of hepatocyte growth factor (HGF) and HGF receptor (c-met) proteins in liver diseases: an immunohistochemical study.

  1999cited by this paper
• Phosphatidylinositol 3-kinase contributes to Erk1/Erk2 MAP kinase activation associated with hepatocyte growth factor-induced cell scattering.

  1999cited by this paper
• Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer.

  1999cited by this paper
• Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas

  1998cited by this paper
• Induction of epithelial tubules by growth factor HGF depends on the STAT pathway

  1998cited by this paper
• Cooperative Interaction between α- and β-Chains of Hepatocyte Growth Factor on c-Met Receptor Confers Ligand-induced Receptor Tyrosine Phosphorylation and Multiple Biological Responses*

  1998cited by this paper
• Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met,TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas.

  1997cited by this paper
• Expression of hepatocyte growth factor and its receptor c‐met proto‐oncogene in hepatocellular carcinoma

  1997cited by this paper
• Pathways Downstream of Shc and Grb2 Are Required for Cell Transformation by the Tpr-Met Oncoprotein*

  1996cited by this paper
• Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis

  1996cited by this paper
• Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor

  1995cited by this paper
• Scatter factor/hepatocyte growth factor is essential for liver development

  1995cited by this paper
• Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer.

  1995cited by this paper
• A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family.

  1994cited by this paper
• Expression of the c‐met protooncogene in human hepatocellular carcinoma

  1994cited by this paper
• c‐met mRNA overexpression in human hepatocellular carcinoma

  1994cited by this paper
• A novel recognition motif for phosphatidylinositol 3-kinase binding mediates its association with the hepatocyte growth factor/scatter factor receptor

  1993cited by this paper
• Localization of hepatocyte growth factor (HGF) gene on human chromosome 7.

  1992cited by this paper
• A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis.

  1992cited by this paper
• Hepatocyte growth factor: molecular structure, roles in liver regeneration, and other biological functions.

  1992cited by this paper
• Lung may have an endocrine function producing hepatocyte growth factor in response to injury of distal organs.

  1992cited by this paper
• Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration

  1991cited by this paper
• Evidence for the identity of human scatter factor and human hepatocyte growth factor.

  1991cited by this paper
• Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET.

  1991cited by this paper
• Tumor cytotoxic factor/hepatocyte growth factor from human fibroblasts: cloning of its cDNA, purification and characterization of recombinant protein.

  1991cited by this paper
• Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product.

  1991cited by this paper
• Organization of the human hepatocyte growth factor-encoding gene.

  1991cited by this paper
• Regional localization of the hepatocyte growth factor (HGF) gene to human chromosome 7 band q21.1.

  1991cited by this paper
• Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor.

  1991cited by this paper
• Possible endocrine control by hepatocyte growth factor of liver regeneration after partial hepatectomy.

  1991cited by this paper
• Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells

  1990cited by this paper
• Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement.

  1989cited by this paper
• Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure.

  1988cited by this paper
• Scatter factor is a fibroblast-derived modulator of epithelial cell mobility

  1987cited by this paper
• Purification and subunit structure of hepatocyte growth factor from rat platelets

  1987cited by this paper
• The human met oncogene is related to the tyrosine kinase oncogenes

  1985cited by this paper
• Partial characterization of a hepatocyte growth factor from rat platelets

  1984cited by this paper
• Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats.

  1984cited by this paper

• The paradigm of stem cell secretome in tissue repair and regeneration: Present and future perspectives

  2025cites this paper
• Cytokine signatures in post-endoscopic retrograde cholangiopancreatography pancreatitis: a pilot study

  2024cites this paper
• Effect of Hepatic Pathology on Liver Regeneration: The Main Metabolic Mechanisms Causing Impaired Hepatic Regeneration

  2023cites this paper
• RNase2 is a possible trigger of acute-on-chronic inflammation leading to mRNA vaccine-associated cardiac complication

  2023cites this paper
• Unveiling the power of microenvironment in liver regeneration: an in-depth overview

  2023cites this paper
• The role of gut microbiota in liver regeneration

  2022cites this paper
• HGF/c-Met: A Key Promoter in Liver Regeneration

  2022cites this paper
• Roles of growth factors in eye development and ophthalmic diseases.

  2022cites this paper
• Current strategies to induce liver remnant hypertrophy before major liver resection

  2021cites this paper
• Local administration of anti-hepatocyte growth factor-neutralizing antibody reverts naturally occurring periodontitis.

  2021cites this paper
• Hepatocyte Growth Factor Overexpression Slows the Progression of 4NQO-Induced Oral Tumorigenesis

  2021cites this paper
• A narrative review of liver regeneration—from models to molecular basis

  2021cites this paper
• Ultra-high Magnification Endocytoscopy and Molecular Markers for Defining Endoscopic and Histologic Remission in Ulcerative Colitis—An Exploratory Study to Define Deep Remission

  2021cites this paper
• Molecular pathways of liver regeneration: A comprehensive review

  2021cites this paper
• RETRACTED ARTICLE: Inducible nitric oxide synthase promotes differentiation of satellite cells and prevents stress urinary incontinence via HGF-mediated p38/MAPK signaling

  2020cites this paper
• Diyabetik ve Nondiyabetik Farelerin Böbrek Dokusunda HGF ve PCNA’nın İmmunohistokimyasal Dağılımı

  2020cites this paper
• Epigenetic Silencing of LMX1A Contributes to Cancer Progression in Lung Cancer Cells

  2020cites this paper
• Applications of Nanobiomaterials in the Therapy and Imaging of Acute Liver Failure

  2020cites this paper
• ATSC transplantation contributes to liver regeneration following paracetamol-induced acute liver injury through differentiation into hepatic-like cells.

  2020cites this paper
• Efficacy of nonviral gene transfer of human hepatocyte growth factor (HGF) against ischemic-reperfusion nerve injury in rats

  2020cites this paper
• Virtual Screening Guided Design, Synthesis and Bioactivity Study of Benzisoselenazolones (BISAs) on Inhibition of c-Met and Its Downstream Signalling Pathways

  2019cites this paper
• Dysregulation of the cohesin subunit RAD21 by Hepatitis C virus mediates host–virus interactions

  2019cites this paper
• Targeting the Hepatocyte Growth Factor Receptor to Overcome Resistance to Targeted Therapies

  2019cites this paper
• Contributions of Fibroblasts, Extracellular Matrix, Stiffness, and Mechanosensing to Hepatocarcinogenesis

  2019cites this paper
• Gene therapy and cell therapy for the management of radiation damages to healthy tissues: Rationale and early results.

  2019cites this paper
• Identification of HGF as a novel target of miR-15a/16/195 in gastric cancer

  2019cites this paper
• Aberrant Cyclin E and Hepatocyte Growth Factor Expression, Microvascular Density, and Micro-Lymphatic Vessel Density in Esophageal Squamous Cell Carcinoma

  2019cites this paper
• Characterization and Evaluation of HGF-Loaded PLGA Nanoparticles in a CCl 4-Induced Acute Liver Injury Mouse Model

  2019cites this paper
• Angiocrine Hgf signaling controls physiologic organ and body size and dynamic hepatocyte proliferation to prevent liver damage during regeneration.

  2019cites this paper
• The influence of dexmedetomidine and propofol on circulating cytokine levels in healthy subjects

  2019cites this paper
• Characterization and Evaluation of HGF-Loaded PLGA Nanoparticles in a CCl4-Induced Acute Liver Injury Mouse Model

  2019cites this paper
• Human Biomarkers of Outcome Following Rift Valley Fever Virus Infection

  2018cites this paper
• Exosomes serve as nanoparticles to suppress tumor growth and angiogenesis in gastric cancer by delivering hepatocyte growth factor siRNA

  2018cites this paper
• Challenges facing antiangiogenesis therapy: The significant role of hypoxia‐inducible factor and MET in development of resistance to anti‐vascular endothelial growth factor‐targeted therapies

  2018cites this paper
• Growth factor modulation of equine trophoblast mitosis and prostaglandin gene expression.

  2018cites this paper
• [Portal vein embolization: Present and future].

  2017cites this paper
• HGFA Is an Injury-Regulated Systemic Factor that Induces the Transition of Stem Cells into GAlert.

  2017cites this paper
• Genomic Changes Associated with Reproductive and Migratory Ecotypes in Sockeye Salmon (Oncorhynchus nerka)

  2017cites this paper
• Functions of pancreatic stellate cell-derived soluble factors in the microenvironment of pancreatic ductal carcinoma

  2017cites this paper
• Validation of VX2 as a Hepatocellular Carcinoma Model: Comparison of the Molecular Reaction of VX2 and HepG2 Tumor Cells to Sorafenib In Vitro.

  2017cites this paper
• Biological roles of hepatocyte growth factor-Met signaling from genetically modified animals.

  2017cites this paper
• MET Tyrosine Kinase Inhibition Enhances the Antitumor Efficacy of an HGF Antibody

  2017cites this paper
• MET exon 14 juxtamembrane splicing mutations: clinical and therapeutical perspectives for cancer therapy.

  2017influential citation
• Quantification of growth factor signaling and pathway cross talk by live-cell imaging.

  2017cites this paper
• Receptor Tyrosine Kinases and the Insulin Signaling System

  2017cites this paper
• Functional heterogeneity in tumor-derived human pancreatic stellate cells: Differential expression of HGF and implications for mitogenic signaling and migration in pancreatic cancer cells

  2017cites this paper
• Label-free Proteomic Analysis of Exosomes Derived from Inducible Hepatitis B Virus-Replicating HepAD38 Cell Line*

  2017cites this paper
• DEVELOPMENT OF RATIONAL COMBINATION THERAPY WITH PARP INHIBITORS AND KINASE INHIBITORS IN TNBC

  2016cites this paper
• Microengineered cancer-on-a-chip platforms to study the metastatic microenvironment.

  2016cites this paper